DNASE2
Basic information
Region (hg38): 19:12875209-12881595
Previous symbols: [ "DNL", "DNL2" ]
Links
Phenotypes
GenCC
Source:
- autoinflammatory-pancytopenia syndrome due to DNASE2 deficiency (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Autoinflammatory-pancytopenia syndrome | AR | Allergy/Immunology/Infectious | The condition can involve autoinflammatory sequelae, and medical management (eg , via JAK inhibition) has been described as beneficial | Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Neurologic; Renal | 29259162; 31775019 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (155 variants)
- not_specified (28 variants)
- Autoinflammatory-pancytopenia_syndrome_due_to_DNASE2_deficiency (5 variants)
- DNASE2-related_disorder (5 variants)
- Systemic_lupus_erythematosus (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DNASE2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000001375.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 46 | 48 | ||||
| missense | 78 | 89 | ||||
| nonsense | 4 | |||||
| start loss | 0 | |||||
| frameshift | 1 | |||||
| splice donor/acceptor (+/-2bp) | 1 | |||||
| Total | 3 | 0 | 85 | 51 | 4 |
Highest pathogenic variant AF is 0.0000027361802
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| DNASE2 | protein_coding | protein_coding | ENST00000222219 | 6 | 6258 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.000452 | 0.968 | 125732 | 0 | 16 | 125748 | 0.0000636 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.644 | 170 | 195 | 0.870 | 0.0000104 | 2336 |
| Missense in Polyphen | 67 | 81.263 | 0.82448 | 970 | ||
| Synonymous | 0.0233 | 88 | 88.3 | 0.997 | 0.00000539 | 720 |
| Loss of Function | 1.91 | 8 | 16.3 | 0.490 | 7.28e-7 | 164 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000185 | 0.000185 |
| Ashkenazi Jewish | 0.0000992 | 0.0000992 |
| East Asian | 0.000109 | 0.000109 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.0000618 | 0.0000615 |
| Middle Eastern | 0.000109 | 0.000109 |
| South Asian | 0.0000980 | 0.0000980 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Hydrolyzes DNA under acidic conditions with a preference for double-stranded DNA. Plays a major role in the degradation of nuclear DNA in cellular apoptosis during development. Necessary for proper fetal development and for definitive erythropoiesis in fetal liver, where it degrades nuclear DNA expelled from erythroid precursor cells.;
- Pathway
- Lysosome - Homo sapiens (human);Lysosome Vesicle Biogenesis;Clathrin derived vesicle budding;trans-Golgi Network Vesicle Budding;Vesicle-mediated transport;Membrane Trafficking
(Consensus)
Recessive Scores
- pRec
- 0.131
Intolerance Scores
- loftool
- 0.497
- rvis_EVS
- 0.39
- rvis_percentile_EVS
- 76.05
Haploinsufficiency Scores
- pHI
- 0.0752
- hipred
- N
- hipred_score
- 0.247
- ghis
- 0.394
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.827
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dnase2a
- Phenotype
- growth/size/body region phenotype; endocrine/exocrine gland phenotype; muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype; skeleton phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; immune system phenotype;
Gene ontology
- Biological process
- DNA metabolic process;apoptotic DNA fragmentation;erythrocyte differentiation;regulation of immune response
- Cellular component
- lysosome;extracellular exosome
- Molecular function
- DNA binding;deoxyribonuclease II activity